Home/Filings/4/0001093557-25-000195
4//SEC Filing

Coleman Jon 4

Accession 0001093557-25-000195

CIK 0001093557other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 4:12 PM ET

Size

4.8 KB

Accession

0001093557-25-000195

Insider Transaction Report

Form 4
Period: 2025-05-22
Coleman Jon
EVP, Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2025-05-22+68,73868,738 total
Footnotes (1)
  • [F1]Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in four equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

Issuer

DEXCOM INC

CIK 0001093557

Entity typeother

Related Parties

1
  • filerCIK 0001442689

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:12 PM ET
Size
4.8 KB